After peaking near $151 in May 2026, Rocket Lab Corporation (NASDAQ: RKLB) has endured a punishing drawdown of more than 55%, wiping out the year's gains and sending shares tumbling into the mid-$60s. The speed and severity of the sell-off — driven by a broader post-SpaceX IPO rotation out of space stocks, a dilutive equity offering, and a securities class action — has left investors asking whether the stock can mount a meaningful recovery. The $100 round-number level has emerged as the most visible near-term milestone: it sits just below the analyst consensus, represents the threshold that separated the stock's rally phase from its correction, and carries the psychological weight that round numbers command in technical analysis.
Rocket Lab is an end-to-end space company headquartered in Long Beach, California, founded in 2006 by CEO Sir Peter Beck. Unlike pure-play launch providers, Rocket Lab operates across two segments: Launch Services, anchored by the frequently flown Electron small orbital rocket, and Space Systems, which designs and manufactures satellites, spacecraft components, and on-orbit infrastructure. The company has delivered more than 1,700 satellites to orbit, operates three launch pads across New Zealand and Virginia, and is developing Neutron, a medium-lift reusable rocket designed to compete directly with SpaceX's Falcon 9 in the constellation-deployment and national security markets. I also checked this using Tickeron’s AI Screener to see how the stock compares to others in the industry.
The single most important variable for the Rocket Lab thesis is Neutron's debut flight, now targeted for the fourth quarter of 2026. A successful first launch would make Rocket Lab eligible to compete for individual task orders under the Space Force's National Security Space Launch (NSSL) Phase 3 Lane 1 program, a contract vehicle carrying a $5.6 billion ceiling through 2029. The Archimedes engine that powers Neutron recently completed a full-duration qualification burn at NASA's Stennis Space Center — a milestone that keeps the timeline credible despite an earlier tank-test failure that pushed the schedule from mid-2026 into the fourth quarter.
Beyond Neutron, the fundamental momentum is difficult to dismiss. First-quarter fiscal 2026 revenue reached $200.35 million, up 63.5% year over year, while the contracted backlog swelled to a record $2.2 billion. Rocket Lab also secured an $816 million Space Development Agency contract for 18 tracking-layer satellites and was selected alongside Raytheon for the Golden Dome Space-Based Interceptor program — placing the company at the center of the highest-priority U.S. defense space budgets.
The pending $8 billion acquisition of Iridium Communications, announced in late June 2026, represents a transformative bet. If the deal closes as expected in mid-2027, Rocket Lab would add a global satellite communications network, L-band spectrum, and more than 2.5 million recurring subscribers — evolving from a launch provider into a vertically integrated space platform that more closely resembles the SpaceX model Morgan Stanley has cited in its analysis.
The broader analyst community remains constructive despite the sell-off. Across 22 analysts, the consensus rating is Moderate Buy, with an average price target of approximately $110, implying roughly 72% upside from the most recent close. High-profile targets include Needham at $120, Keybanc at $135, and Bank of America at $115. Morgan Stanley maintains an Overweight rating with a $105 base case while simultaneously raising its bull-case scenario to $293, reflecting the optionality tied to Neutron, Iridium, and Golden Dome contract conversions. On the more cautious side, Piper Sandler initiated coverage in mid-July with a Neutral rating and an $83 target, arguing the stock remains expensive even after falling more than 50% from its peak. The range of opinion — from $60 at Wells Fargo to $150 at the high end — underscores how much depends on execution over the next two quarters.
Rocket Lab remains an unprofitable company. Fiscal 2025 revenue of $601.8 million was accompanied by a net loss of $198 million, and the company trades at roughly 66 times trailing sales — a multiple that prices in years of flawless execution. Any Neutron delay beyond late 2026, whether from technical setbacks or certification hurdles, would delay the medium-lift revenue stream that the valuation thesis depends on and could trigger further equity dilution.
Additional headwinds include a $3 billion at-the-market equity offering announced in June, which raised dilution concerns, and insider selling from CEO Peter Beck, who disclosed the sale of nearly 3 million shares in early July. A securities class action filed over Neutron timeline disclosures has added legal uncertainty to the mix. Meanwhile, the post-SpaceX IPO rotation has not yet run its course, and with a beta of approximately 2.55, RKLB amplifies every shift in market sentiment — in both directions.
From a technical perspective, $100 also aligns as the approximate midpoint between the 52-week high of $151 and key support near $60 — the Street-low analyst target and a level the stock tested during the recent sell-off. The 200-day simple moving average, sitting around $76, represents a nearer-term hurdle; the stock would need to reclaim that level before any sustained move toward triple digits gains credibility. The $80 to $85 zone, where the stock consolidated during portions of June and early July, may also act as an intermediate resistance area. I reviewed the recent patterns using Tickeron’s AI Pattern Search Engine to confirm the key levels.
One tool I’ve found helpful for navigating stocks like this is Tickeron’s AI Daily Buy/Sell Signals. It uses artificial intelligence to continuously monitor thousands of stocks and ETFs, generating Buy, Sell, or Hold signals based on evolving market conditions, technical patterns, and AI-driven analysis. Rather than manually scanning charts and news feeds, I can use these signals to identify emerging opportunities, monitor existing positions, and spot shifts in market trends more efficiently. For investors tracking whether RKLB can sustain a recovery toward $100, automated signal monitoring can help filter the noise from the signal.
Can Rocket Lab reach $100? The arithmetic says yes — a 56% rally from $63.91 is well within this stock's normal range of motion, and it has already traded well above $100 earlier in 2026. The question is less about capability and more about timing and conditions. A clean Neutron debut in the fourth quarter, continued backlog conversion at or above current growth rates, and tangible progress on the Iridium integration would likely provide the fundamental fuel to drive shares back through $100. Conversely, a Neutron delay into 2027, further dilution, or deteriorating sentiment across the space sector would make that target considerably more difficult. For now, $100 remains a reachable but non-trivial milestone — one that demands execution, not merely ambition. The upcoming Q2 earnings report on August 6 may offer the next meaningful signal about which direction the stock is poised to take.
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
RKLB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options. In of 29 cases where RKLB's price broke its lower Bollinger Band, its price rose further in the following month. The odds of a continued upward trend are .
The RSI Indicator entered the oversold zone -- be on the watch for RKLB's price rising or consolidating in the future. That's also the time to consider buying the stock or exploring call options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 12 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
The Moving Average Convergence Divergence (MACD) for RKLB just turned positive on July 06, 2026. Looking at past instances where RKLB's MACD turned positive, the stock continued to rise in of 45 cases over the following month. The odds of a continued upward trend are .
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where RKLB advanced for three days, in of 298 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Momentum Indicator moved below the 0 level on July 13, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on RKLB as a result. In of 92 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are .
RKLB moved below its 50-day moving average on June 22, 2026 date and that indicates a change from an upward trend to a downward trend.
The 10-day moving average for RKLB crossed bearishly below the 50-day moving average on June 24, 2026. This indicates that the trend has shifted lower and could be considered a sell signal. In of 10 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .
Following a 3-day decline, the stock is projected to fall further. Considering past instances where RKLB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
The Aroon Indicator for RKLB entered a downward trend on July 24, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating fairly steady price growth. RKLB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating well-balanced risk and returns. The average Profit vs. Risk Rating rating for the industry is 73, placing this stock slightly better than average.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (17.637) is normal, around the industry mean (9.810). P/E Ratio (0.000) is within average values for comparable stocks, (119.202). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (4.074). Dividend Yield (0.000) settles around the average of (0.016) among similar stocks. P/S Ratio (52.356) is also within normal values, averaging (34.934).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
Industry AerospaceDefense